Abstract
Somatic hypermutation (SHM) diversifies the genes that encode immunoglobulin variable regions in antigen-activated germinal centre B lymphocytes. Available evidence strongly suggests that DNA deamination potentiates phase I SHM and subsequently triggers phase II SHM. A concise review of this evidence is followed by a detailed critique of two possible models which suggest that polymerase-η potentiates phase II SHM via either its DNA-dependent or its RNA-dependent DNA synthetic activity. Quantitative analysis, in the context of extant data that define the features of SHM, favours the RNA-dependent mechanism.
Original language | English |
---|---|
Pages (from-to) | 557-567 |
Number of pages | 11 |
Journal | Immunology and Cell Biology |
Volume | 82 |
Issue number | 6 |
DOIs | |
Publication status | Published - Dec 2004 |